LifeVantage's Q4 revenue, adj EPS miss estimates on fewer orders

Lifevantage

27/08/2026 21:15

Overview
U.S. health and wellness firm's fiscal Q4 revenue fell 23%, missing analyst expectations
Adjusted EPS for fiscal Q4 declined and missed analyst expectations
Company cites lower order volume, smaller average orders, and weaker MindBody GLP-1 sales for declines

Outlook
Company is not issuing formal guidance for fiscal 2027 due to recent CEO transition

Result Drivers
ORDER VOLUME AND SIZE - Co said revenue decline was mainly due to fewer orders from active accounts and lower average order size
MINDBODY GLP-1 SALES - Co cited lower sales of MindBody GLP-1 System cycling a strong prior-year quarter as a factor in revenue drop
PRODUCT MIX AND COSTS - Gross margin fell due to product mix shift, inventory obsolescence, and increased shipping expenses

Company press release: ID:nGNX724H24

Key Details
Metric
Beat/Miss
Actual
Consensus Estimate
Q4 Revenue
Miss
$42.38 mln
$45.95 mln (3 Analysts)
Q4 Adjusted EPS
Miss
$0.11
$0.13 (3 Analysts)
Q4 Gross Profit
 
$33.04 mln
 
Q4 Operating Expenses
 
$31.38 mln
 
Q4 Operating Income
 
$1.67 mln
 

Analyst Coverage
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 1 "strong buy" or "buy", 1 "hold" and no "sell" or "strong sell"
The average consensus recommendation for the pharmaceuticals peer group is "buy"
Wall Street's median 12-month price target for LifeVantage Corp is $7.00, about 5.9% above its August 26 closing price of $6.61
The stock recently traded at 14 times the next 12-month earnings vs. a P/E of 8 three months ago

Reuters Recommended Reads
Aug 25 - Sweden's Zinzino Q2 revenue rises 18%, profitability improves
Aug 25 - More US employers to drop weight-loss drugs in 2027, as healthcare costs increase
Aug 25 - China's H&H International half-year revenue rises, profit surges on margin expansion 

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)